Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Clinical trial NCT03109080 · COMPLETED

Trial details

NCT number: NCT03109080
Sponsor: Institut Curie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms, Triple-Negative Breast Neoplasm Malignant Female Radiotherapy Side Effect

Start date: 2017-07-24
Primary completion: 2020-02-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.